STOCK TITAN
  1. Home
  2. Financials
  3. APLS
  4. Revenue

Apellis Pharmaceuticals, Inc. (APLS) Revenue by Year

APLS

Apellis Pharmaceuticals, Inc. generated $1.0B in revenue in fiscal year 2025. This represents an increase of 28.5% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $1.1B in revenue. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Apellis Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Revenue $1.0B
YoY +28.5%
5Y CAGR +32.0%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

APLS Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Revenue$1.1B$1.0B+28.5%$781.4M+97.0%$396.6M+425.8%$75.4M+13.3%$66.6M-73.4%$250.6MN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

APLS Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$268.3M+60.9%$199.9M-5.9%$458.6M+133.0%$178.5M-10.6%$166.8M-3.2%$212.5M+45.2%$196.8M+78.3%$199.7M+110.3%$172.3M+284.3%$146.4M+545.9%$110.4M+400.5%$95.0M+481.8%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Apellis Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Apellis Pharmaceuticals, Inc.'s revenue in fiscal year 2025?

Apellis Pharmaceuticals, Inc. generated $1.0B in revenue in fiscal year 2025.

How fast is Apellis Pharmaceuticals, Inc.'s revenue growing?

Apellis Pharmaceuticals, Inc. (APLS) revenue rose by 28.5% year over year, from $781.4M to $1.0B in fiscal year 2025.

What is Apellis Pharmaceuticals, Inc.'s revenue over the last twelve months?

Apellis Pharmaceuticals, Inc. (APLS) reported $1.1B in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Apellis Pharmaceuticals, Inc. (APLS) reported $268.3M in revenue in Q1 2026. This represents an increase of 60.9% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Apellis Pharmaceuticals, Inc. (APLS) reported on that line in every period on record.